Wave Life Sciences
(NASDAQ) WVE
Wave Life Sciences Financials at a Glance
Market Cap
$2.32B
Revenue (TTM)
$42.73M
Net Income (TTM)
$204.38M
EPS (TTM)
$-1.21
P/E Ratio
-10.15
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Price
$6.17
Volume
50,132,246.906
Open
$5.36
Price
$6.17
Volume
50,132,246.906
Open
$5.36
Previous Close
$6.20
Daily Range
$5.02 - $6.49
52-Week Range
$5.02 - $21.73
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Price
$6.17
Volume
50,132,246.906
Open
$5.36
Previous Close
$6.20
Daily Range
$5.02 - $6.49
52-Week Range
$5.02 - $21.73
WVE News
WVE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Wave Life Sciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
317
CEO
Paul B. Bolno, MD, MBA
Website
www.wavelifesciences.comHeadquarters
Singapore, 018936, SG
WVE Financials
Key Financial Metrics (TTM)
Gross Margin
85%
Operating Margin
-5%
Net Income Margin
-5%
Return on Equity
-55%
Return on Capital
-40%
Return on Assets
-32%
Earnings Yield
-9.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.32B
Shares Outstanding
188.25M
Volume
50.13M
Short Interest
0.00%
Avg. Volume
3.27M
Financials (TTM)
Gross Profit
$33.88M
Operating Income
$215.38M
EBITDA
$195.53M
Operating Cash Flow
$187.49M
Capital Expenditure
$718.00K
Free Cash Flow
$187.49M
Cash & ST Invst.
$602.07M
Total Debt
$17.77M
Wave Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$17.25M
-79.4%
Gross Profit
$14.98M
-82.1%
Gross Margin
86.88%
N/A
Market Cap
$2.32B
N/A
Market Cap/Employee
$8.07M
N/A
Employees
287
N/A
Net Income
$53.18M
-281.8%
EBITDA
$50.92M
-302.7%
Quarterly Fundamentals
Net Cash
$584.30M
+111.2%
Accounts Receivable
$1.28M
-10.3%
Inventory
$0.00
N/A
Long Term Debt
$9.40M
-47.1%
Short Term Debt
$8.36M
+9.5%
Return on Assets
-32.01%
N/A
Return on Invested Capital
-39.63%
N/A
Free Cash Flow
$32.11M
+26.6%
Operating Cash Flow
$32.12M
+26.4%